Amany O. Kamel

1.7k total citations
36 papers, 1.4k citations indexed

About

Amany O. Kamel is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Amany O. Kamel has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmaceutical Science, 20 papers in Molecular Biology and 5 papers in Biomaterials. Recurrent topics in Amany O. Kamel's work include Advancements in Transdermal Drug Delivery (16 papers), Advanced Drug Delivery Systems (16 papers) and Lipid Membrane Structure and Behavior (8 papers). Amany O. Kamel is often cited by papers focused on Advancements in Transdermal Drug Delivery (16 papers), Advanced Drug Delivery Systems (16 papers) and Lipid Membrane Structure and Behavior (8 papers). Amany O. Kamel collaborates with scholars based in Egypt, Canada and United Kingdom. Amany O. Kamel's co-authors include Azza A. Mahmoud, Gehanne A.S. Awad, Omaima A. Sammour, Ahmed Hassen Elshafeey, Mayssa Abdel Hady, Salama Ha, Salwa Salah, Nahed D. Mortada, Shawn Wettig and Taksim Ahmed and has published in prestigious journals such as ACS Nano, Carbohydrate Polymers and International Journal of Pharmaceutics.

In The Last Decade

Amany O. Kamel

36 papers receiving 1.4k citations

Peers

Countries citing papers authored by Amany O. Kamel

Since Specialization

Citations

This map shows the geographic impact of Amany O. Kamel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amany O. Kamel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amany O. Kamel more than expected).

Fields of papers citing papers by Amany O. Kamel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amany O. Kamel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amany O. Kamel. The network helps show where Amany O. Kamel may publish in the future.

Co-authorship network of co-authors of Amany O. Kamel

This figure shows the co-authorship network connecting the top 25 collaborators of Amany O. Kamel. A scholar is included among the top collaborators of Amany O. Kamel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amany O. Kamel. Amany O. Kamel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A new era of psoriasis treatment: Drug repurposing through the lens of nanotechnology and machine learning 2025 ·International Journal of Pharmaceutics ·(unknown), Riham I. El-Gogary, Amany O. Kamel	3
2	Novel green-based polyglycerol polymeric nanoparticles loaded with ferulic acid: A promising approach for hepatoprotection 2024 ·International Journal of Biological Macromolecules ·(unknown), Riham I. El-Gogary, Mahmoud E. Soliman, Amany O. Kamel	3
3	Rhamnosomes: A new generation of flexible vesicles for a boosted targeted nose-to-brain delivery of selegiline in the treatment of Parkinson's disease 2024 ·Journal of Drug Delivery Science and Technology ·(unknown), Ghada M. El-Zaafarany, Amany O. Kamel	2
4	Nano-vesicular systems for melanocytes targeting and melasma treatment: In-vitro characterization, ex-vivo skin retention, and preliminary clinical appraisal 2024 ·International Journal of Pharmaceutics ·Shymaa Hatem, Amany O. Kamel, Seham A. Elkheshen, Maha Nasr, Noha H. Moftah, (unknown), (unknown), (unknown)	6
5	Ethyl lauroyl arginate-based hydrophobic ion pair complex in lipid nanocapsules: A novel oral delivery approach of rosmarinic acid for enhanced permeability and bioavailability 2022 ·International Journal of Pharmaceutics ·Heba A. Gad, Rania A.H. Ishak, Rola M. Labib, Amany O. Kamel	9
6	Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs 2021 ·European Journal of Pharmaceutical Sciences ·(unknown), Amany O. Kamel, (unknown), Samar Mansour	32
7	A natural protein based platform for the delivery of Temozolomide acid to glioma cells 2021 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), (unknown), Shunping Han, Julie Wang, Adam A. Walters, Mona M.A. Abdel-Mottaleb, Amany O. Kamel, Ahmed S. Geneidi, Gehanne A.S. Awad, Khuloud T. Al‐Jamal	14
8	Novel polyglycerol-dioleate based cubosomal dispersion with tailored physical characteristics for controlled delivery of ondansetron 2017 ·Colloids and Surfaces B Biointerfaces ·Mai Mansour, Amany O. Kamel, Samira Mansour, Nahed D. Mortada	20
9	Injectable long acting chitosan/tripolyphosphate microspheres for the intra-articular delivery of lornoxicam: Optimization and in vivo evaluation 2016 ·Carbohydrate Polymers ·Hend Abd-Allah, Amany O. Kamel, Omaima A. Sammour	54
10	Terbinafine hydrochloride nanovesicular gel: In vitro characterization, ex vivo permeation and clinical investigation 2016 ·European Journal of Pharmaceutical Sciences ·(unknown), Amany O. Kamel, Omaima A. Sammour, Shady M. Ibrahim	31
11	Polyethylene Glycol Conjugated Polymeric Nanocapsules for Targeted Delivery of Quercetin to Folate-Expressing Cancer Cellsin Vitroandin Vivo 2014 ·ACS Nano ·Riham I. El-Gogary, Noelia Rubio, Julie Wang, Wafa’ T. Al-Jamal, Maxime Bourgognon, Houmam Kafa, (unknown), Rebecca Klippstein, Vincenzo Abbate, Frédéric R. Leroux, Sara Bals, Gustaaf Van Tendeloo, Amany O. Kamel, Gehanne A.S. Awad, Nahed D. Mortada, Khuloud T. Al‐Jamal	153
12	Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route 2014 ·International Journal of Pharmaceutics ·(unknown), Amany O. Kamel, Omaima A. Sammour, Ahmed Hassen Elshafeey	113
13	Vesicular powder as carrier for doxycycline hydrochloride and metronidazole combination therapy 2013 ·Pharmaceutical Development and Technology ·Heba A. Gad, Amany O. Kamel, Omaima A. Sammour, (unknown)	7
14	Anticancer effect of atorvastatin nanostructured polymeric micelles based on stearyl-grafted chitosan 2012 ·International Journal of Biological Macromolecules ·(unknown), Amany O. Kamel, Gehanne A.S. Awad, Nahed D. Mortada	37
15	Brain delivery of olanzapine by intranasal administration of transfersomal vesicles 2012 ·Journal of Liposome Research ·Salama Ha, Azza A. Mahmoud, Amany O. Kamel, Mayssa Abdel Hady, Gehanne A.S. Awad	130
16	Enhancement of Human Oral Bioavailability and <I>In Vitro</I> Antitumor Activity of Rosuvastatin via Spray Dried Self-Nanoemulsifying Drug Delivery System 2012 ·Journal of Biomedical Nanotechnology ·Amany O. Kamel, Azza A. Mahmoud	29
17	Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide 2012 ·International Journal of Nanomedicine ·Amany O. Kamel, (unknown), (unknown), (unknown)	47
18	Nanosized Particulate Systems for Dermal and Transdermal Delivery 2010 ·Journal of Biomedical Nanotechnology ·Amany O. Kamel, Ahmed Hassen Elshafeey	16
19	Preparation of Intravenous Stealthy Acyclovir Nanoparticles with Increased Mean Residence Time 2009 ·AAPS PharmSciTech ·Amany O. Kamel, Gehanne A.S. Awad, Ahmed S. Geneidi, Nahed D. Mortada	35
20	Ammonium methacrylate units polymer content and their effect on acyclovir colloidal nanoparticles properties and bioavailability in human volunteers 2009 ·Colloids and Surfaces B Biointerfaces ·Ahmed Hassen Elshafeey, Amany O. Kamel, Gehanne A.S. Awad	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact